Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 323

1.

A tutorial on dynamic risk prediction of a binary outcome based on a longitudinal biomarker.

Dandis R, Teerenstra S, Massuger L, Sweep F, Eysbouts Y, IntHout J.

Biom J. 2019 Nov 28. doi: 10.1002/bimj.201900044. [Epub ahead of print]

PMID:
31777998
2.

Downregulation of matrix Gla protein is a biomarker for tamoxifen-resistant and radioresistant breast cancer.

Post AE, Bussink J, Smid M, Sweep FC, Span PN.

Biomark Med. 2019 Jul;13(10):841-850. doi: 10.2217/bmm-2019-0050. Epub 2019 Jul 18.

PMID:
31317787
3.

Glucocorticoid Activity of Adrenal Steroid Precursors in Untreated Patients With Congenital Adrenal Hyperplasia.

Engels M, Pijnenburg-Kleizen KJ, Utari A, Faradz SMH, Oude-Alink S, van Herwaarden AE, Span PN, Sweep FC, Claahsen-van der Grinten HL.

J Clin Endocrinol Metab. 2019 Nov 1;104(11):5065-5072. doi: 10.1210/jc.2019-00547.

PMID:
31090904
4.

Changes in DNA damage repair gene expression and cell cycle gene expression do not explain radioresistance in tamoxifen-resistant breast cancer.

Post AEM, Bussink J, Sweep FCGJ, Span PN.

Oncol Res. 2019 Apr 18. doi: 10.3727/096504019X15555794826018. [Epub ahead of print]

PMID:
31046897
5.

Testicular Adrenal Rest Tumors: Current Insights on Prevalence, Characteristics, Origin, and Treatment.

Engels M, Span PN, van Herwaarden AE, Sweep FCGJ, Stikkelbroeck NMML, Claahsen-van der Grinten HL.

Endocr Rev. 2019 Aug 1;40(4):973-987. doi: 10.1210/er.2018-00258. Review.

PMID:
30882882
6.

Ultrafine particles and ozone perturb norepinephrine clearance rather than centrally generated sympathetic activity in humans.

Heusser K, Tank J, Holz O, May M, Brinkmann J, Engeli S, Diedrich A, Framke T, Koch A, Großhennig A, Jan Danser AH, Sweep FCGJ, Schindler C, Schwarz K, Krug N, Jordan J, Hohlfeld JM.

Sci Rep. 2019 Mar 6;9(1):3641. doi: 10.1038/s41598-019-40343-w.

7.

The circular RNome of primary breast cancer.

Smid M, Wilting SM, Uhr K, Rodríguez-González FG, de Weerd V, Prager-Van der Smissen WJC, van der Vlugt-Daane M, van Galen A, Nik-Zainal S, Butler A, Martin S, Davies HR, Staaf J, van de Vijver MJ, Richardson AL, MacGrogan G, Salgado R, van den Eynden GGGM, Purdie CA, Thompson AM, Caldas C, Span PN, Sweep FCGJ, Simpson PT, Lakhani SR, Van Laere S, Desmedt C, Paradiso A, Eyfjord J, Broeks A, Vincent-Salomon A, Futreal AP, Knappskog S, King T, Viari A, Børresen-Dale AL, Stunnenberg HG, Stratton M, Foekens JA, Sieuwerts AM, Martens JWM.

Genome Res. 2019 Mar;29(3):356-366. doi: 10.1101/gr.238121.118. Epub 2019 Jan 28.

8.

Conditioning cortisol in humans: design and pilot study of a randomized controlled trial.

Tekampe J, van Middendorp H, Sweep FCGJ, Roerink SHPP, Hermus ARMM, Evers AWM.

Pilot Feasibility Stud. 2019 Jan 18;5:9. doi: 10.1186/s40814-018-0382-5. eCollection 2019.

9.

The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis.

Rijvers L, Melief MJ, van der Vuurst de Vries RM, Stéphant M, van Langelaar J, Wierenga-Wolf AF, Hogervorst JM, Geurts-Moespot AJ, Sweep FCGJ, Hintzen RQ, van Luijn MM.

Eur J Immunol. 2018 Nov;48(11):1861-1871. doi: 10.1002/eji.201847623. Epub 2018 Sep 25.

10.

Human Pharmacological Conditioning of the Immune and Endocrine System: Challenges and Opportunities.

Tekampe J, van Middendorp H, Sweep FCGJ, Roerink SHPP, Hermus ARMM, Evers AWM.

Int Rev Neurobiol. 2018;138:61-80. doi: 10.1016/bs.irn.2018.01.002. Epub 2018 Apr 2. Review.

PMID:
29681335
11.

Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer.

Post AEM, Smid M, Nagelkerke A, Martens JWM, Bussink J, Sweep FCGJ, Span PN.

Clin Cancer Res. 2018 Jul 15;24(14):3397-3408. doi: 10.1158/1078-0432.CCR-17-2551. Epub 2018 Apr 16.

12.

HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients.

Abbink K, Zusterzeel PL, Geurts-Moespot AJ, Herwaarden AEV, Pijnenborg JM, Sweep FC, Massuger LF.

Tumour Biol. 2018 Feb;40(2):1010428318757103. doi: 10.1177/1010428318757103.

PMID:
29463191
13.

Gonadal function in adult male patients with congenital adrenal hyperplasia.

Engels M, Gehrmann K, Falhammar H, Webb EA, Nordenström A, Sweep FC, Span PN, van Herwaarden AE, Rohayem J, Richter-Unruh A, Bouvattier C, Köhler B, Kortmann BB, Arlt W, Roeleveld N, Reisch N, Stikkelbroeck NMML, Claahsen-van der Grinten HL; dsd-LIFE group.

Eur J Endocrinol. 2018 Mar;178(3):285-294. doi: 10.1530/EJE-17-0862. Epub 2018 Jan 16.

PMID:
29339528
14.

GATA transcription factors in testicular adrenal rest tumours.

Engels M, Span PN, Mitchell RT, Heuvel JJTM, Marijnissen-van Zanten MA, van Herwaarden AE, Hulsbergen-van de Kaa CA, Oosterwijk E, Stikkelbroeck NM, Smith LB, Sweep FCGJ, Claahsen-van der Grinten HL.

Endocr Connect. 2017 Nov;6(8):866-875. doi: 10.1530/EC-17-0215. Epub 2017 Oct 16.

15.

Cardiovascular and metabolic risk in pediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency.

Mooij CF, van Herwaarden AE, Sweep FCGJ, Roeleveld N, de Korte CL, Kapusta L, Claahsen-van der Grinten HL.

J Pediatr Endocrinol Metab. 2017 Aug 28;30(9):957-966. doi: 10.1515/jpem-2017-0068.

PMID:
28787274
16.

Tissue kallikrein-related peptidase 4 (KLK4), a novel biomarker in triple-negative breast cancer.

Yang F, Aubele M, Walch A, Gross E, Napieralski R, Zhao S, Ahmed N, Kiechle M, Reuning U, Dorn J, Sweep F, Magdolen V, Schmitt M.

Biol Chem. 2017 Sep 26;398(10):1151-1164. doi: 10.1515/hsz-2017-0122.

PMID:
28755528
17.

Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer.

De Marchi T, Timmermans MA, Sieuwerts AM, Smid M, Look MP, Grebenchtchikov N, Sweep FCGJ, Smits JG, Magdolen V, van Deurzen CHM, Foekens JA, Umar A, Martens JW.

Sci Rep. 2017 May 18;7(1):2099. doi: 10.1038/s41598-017-02296-w.

18.

Serum Human Chorionic Gonadotropin Normogram for the Detection of Gestational Trophoblastic Neoplasia.

Eysbouts Y, Brouwer R, Ottevanger P, Massuger L, Sweep F, Thomas C, van Herwaarden A.

Int J Gynecol Cancer. 2017 Jun;27(5):1035-1041. doi: 10.1097/IGC.0000000000000966.

PMID:
28498241
19.

Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset.

Eysbouts YK, Ottevanger PB, Massuger LFAG, IntHout J, Short D, Harvey R, Kaur B, Sebire NJ, Sarwar N, Sweep FCGJ, Seckl MJ.

Ann Oncol. 2017 Aug 1;28(8):1856-1861. doi: 10.1093/annonc/mdx211.

20.

The added value of hysterectomy in the management of gestational trophoblastic neoplasia.

Eysbouts YK, Massuger LFAG, IntHout J, Lok CAR, Sweep FCGJ, Ottevanger PB.

Gynecol Oncol. 2017 Jun;145(3):536-542. doi: 10.1016/j.ygyno.2017.03.018. Epub 2017 Apr 5.

PMID:
28390821

Supplemental Content

Support Center